Clinical trial
Cell-Mediated Immune Responses to Cytomegalovirus gB/MF59 Vaccine
NCT00815165 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cell-Mediated Immune Responses to Cytomegalovirus gB/MF59 Vaccine
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- August 31, 2011
- Enrollment
- 165 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.